SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Beyond Air, Inc. – ‘10-K’ for 12/31/17 – ‘EX-31.1’

On:  Friday, 3/30/18, at 9:20am ET   ·   For:  12/31/17   ·   Accession #:  1178913-18-1051   ·   File #:  0-55759

Previous ‘10-K’:  ‘10-K’ on 3/31/17 for 12/31/16   ·   Next:  ‘10-K’ on 6/28/19 for 3/31/19   ·   Latest:  ‘10-K’ on 6/22/23 for 3/31/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/30/18  Beyond Air, Inc.                  10-K       12/31/17   74:5.5M                                   Z-K Global Ltd/FA

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    995K 
 2: EX-23.1     Consent of Experts or Counsel -- exhibit_23-1       HTML     22K 
 3: EX-31.1     Certification -- §302 - SOA'02 -- exhibit_31-1      HTML     31K 
 4: EX-31.2     Certification -- §302 - SOA'02 -- exhibit_31-2      HTML     30K 
 5: EX-32.1     Certification -- §906 - SOA'02 -- exhibit_32-1      HTML     24K 
 6: EX-32.2     Certification -- §906 - SOA'02 -- exhibit_32-2      HTML     23K 
13: R1          Document and Entity Information                     HTML     49K 
14: R2          Consolidated Balance Sheets                         HTML    108K 
15: R3          Consolidated Balance Sheets (Parenthetical)         HTML     40K 
16: R4          Consolidated Statements of Comprehensive Loss       HTML     51K 
17: R5          Statements of Changes in Consolidated               HTML     97K 
                Stockholders' Equity Deficiency                                  
18: R6          Statements of Consolidated Cash Flows               HTML    119K 
19: R7          General                                             HTML     39K 
20: R8          Significant Accounting Policies                     HTML     68K 
21: R9          Other Accounts Receivable                           HTML     34K 
22: R10         Property and Equipment, Net                         HTML     40K 
23: R11         Other Accounts Payable                              HTML     33K 
24: R12         Bank Loan                                           HTML     25K 
25: R13         Convertible Notes                                   HTML     41K 
26: R14         Fair Value Measurement                              HTML     53K 
27: R15         Taxes on Income                                     HTML     65K 
28: R16         Contingent Liabilities and Commitments              HTML     27K 
29: R17         Stockholders' Deficiency                            HTML    101K 
30: R18         Related Party Balances and Transactions             HTML     51K 
31: R19         Financial Expense, Net                              HTML     40K 
32: R20         Basic and Diluted Net Loss Per Share                HTML     37K 
33: R21         Subsequent Events                                   HTML     29K 
34: R22         Significant Accounting Policies (Policies)          HTML    123K 
35: R23         Significant Accounting Policies (Tables)            HTML     32K 
36: R24         Other Accounts Receivable (Tables)                  HTML     31K 
37: R25         Property and Equipment, Net (Tables)                HTML     39K 
38: R26         Other Accounts Payable (Tables)                     HTML     32K 
39: R27         Convertible Notes (Tables)                          HTML     36K 
40: R28         Fair Value Measurement (Tables)                     HTML     48K 
41: R29         Taxes on Income (Tables)                            HTML     57K 
42: R30         Stockholders' Deficiency (Tables)                   HTML     76K 
43: R31         Related Party Balances and Transactions (Tables)    HTML     50K 
44: R32         Financial Expense, Net (Tables)                     HTML     38K 
45: R33         Basic and Diluted Net Loss Per Share (Tables)       HTML     36K 
46: R34         General (Narrative) (Details)                       HTML     55K 
47: R35         Significant Accounting Policies (Schedule of        HTML     30K 
                Estimated useful lives)) (Details)                               
48: R36         Significant Accounting Policies (Fair Value of      HTML     39K 
                Options) (Details)                                               
49: R37         Other Accounts Receivable (Schedule of Other        HTML     28K 
                Accounts Receivable) (Details)                                   
50: R38         Property and Equipment, Net (Schedule of Property   HTML     38K 
                and Equipment) (Details)                                         
51: R39         Other Accounts Payable (Schedule of Other Accounts  HTML     32K 
                Payable) (Details)                                               
52: R40         Bank Loan (Details)                                 HTML     29K 
53: R41         Convertible Notes (Narrative) (Details)             HTML     38K 
54: R42         Convertible Notes (Schedule of Convertible Notes)   HTML     41K 
                (Details)                                                        
55: R43         Fair Value Measurement (Schedule of assumptions to  HTML     41K 
                estimate the Investors' and placement agent's                    
                warrants) (Details)                                              
56: R44         Fair Value Measurement (Schedule of components of   HTML     42K 
                the liability associated with such warrants)                     
                (Details)                                                        
57: R45         Taxes on Income (Narrative) (Details)               HTML     33K 
58: R46         Taxes on Income (Schedule of Deferred Tax Assets)   HTML     37K 
                (Details)                                                        
59: R47         Taxes on Income (Schedule of Income Loss Before     HTML     30K 
                Taxes) (Details)                                                 
60: R48         Taxes on Income (Schedule of Reconciliation of      HTML     26K 
                Unrecognized Tax Benefits) (Details)                             
61: R49         Contingent Liabilities and Commitments (Other)      HTML     27K 
                (Details)                                                        
62: R50         Contingent Liabilities and Commitments (Option      HTML     33K 
                Agreement) (Details)                                             
63: R51         Stockholders' Deficiency (Narrative) (Details)      HTML    191K 
64: R52         Stockholders' Deficiency (Summary of Option         HTML     58K 
                Activity For Employees And Directors) (Details)                  
65: R53         Stockholders' Deficiency (Summary of Options        HTML     44K 
                Granted to Non-Employees) (Details)                              
66: R54         Stockholders' Deficiency (Schedule of Share Based   HTML     33K 
                Compensation Expense) (Details)                                  
67: R55         Related Party Balances and Transactions             HTML     47K 
                (Narrative) (Details)                                            
68: R56         Related Party Balances and Transactions (Schedule   HTML     43K 
                of Related Party Transactions) (Details)                         
69: R57         Financial Expense, Net (Details)                    HTML     40K 
70: R58         Basic and Diluted Net Loss Per Share (Details)      HTML     34K 
71: R59         Subsequent Events (Details)                         HTML     48K 
73: XML         IDEA XML File -- Filing Summary                      XML    133K 
72: EXCEL       IDEA Workbook of Financial Reports                  XLSX     75K 
 7: EX-101.INS  XBRL Instance -- aitb-20171231                       XML   1.34M 
 9: EX-101.CAL  XBRL Calculations -- aitb-20171231_cal               XML    173K 
10: EX-101.DEF  XBRL Definitions -- aitb-20171231_def                XML    458K 
11: EX-101.LAB  XBRL Labels -- aitb-20171231_lab                     XML    943K 
12: EX-101.PRE  XBRL Presentations -- aitb-20171231_pre              XML    723K 
 8: EX-101.SCH  XBRL Schema -- aitb-20171231                         XSD    141K 
74: ZIP         XBRL Zipped Folder -- 0001178913-18-001051-xbrl      Zip    131K 


‘EX-31.1’   —   Certification — §302 – SOA’02 — exhibit_31-1


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C: 


Exhibit 31.1
 
CERTIFICATIONS
 
I, Steven A. Lisi, certify that:
 
1.
I have reviewed this Annual Report on Form 10-K of AIT Therapeutics, Inc.;
 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
(c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
       
   
     
   
Chairman and Chief Executive Officer
 
 




Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:3/30/18
For Period end:12/31/1710-KT
 List all Filings 
Top
Filing Submission 0001178913-18-001051   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 2:45:22.1pm ET